As at April 29, 2012

Tuesday, May 8, 2012 11:00-12:30

Hall A

SATELLITE SYMPOSIUM SPONSORED BY ASTRAZENECA: THE ROLE OF FLUENZ IN PEDIATRIC INFLUENZA PREVENTION Time 11:00

WELCOME AND INTRODUCTION T. Heikkinen, Finland

11:05

CURRENT KNOWLEDGE OF PEDIATRIC INFLUENZA T. Heikkinen, Finland

11:30

THE SAFETY OF EFFICACY OF FLUENZ IN 2-17 YEAR OLDS C. Ambrose, USA

11:55

THE POTENTIAL IMPACT OF FLUENZ ON PEDIATRIC INFLUENZA VACCINATION IN THE EU A. Finn, UK

12:20

Q&A

12:30

Lunch Break

13:30-15:00

Hall A

SATELLITE SYMPOSIUM SPONSORED BY BAXTER: MENINGOCOCCAL C VACCINATION IN CHILDREN – EXPERIENCE AND EVIDENCE Chairperson: J. Findlow, UK LONG-TERM CONTROL OF MENINGOCOCCAL CAPSULAR GROUP C (MENC) DISEASE IN THE UNITED KINGDOM S. Ladhani, London, UK EVALUATION OF MENINGOCOCCAL C CONJUGATE VACCINE SCHEDULES IN CANADIAN CHILDREN: A GUIDE TO PROGRAM STRATEGY S.R.M. Dobson, J.A. Bettinger, Vancouver, BC, Canada MENC VACCINATION IN CHILDREN; THE DUTCH EXPERIENCE F. van der Klis, Bilthoven, The Netherlands IMMUNOGENICITY OF CONJUGATE MENINGOCOCCUS C VACCINE IN PEDIATRIC SOLID ORGAN RECIPIENTS M. Prelog, Würzburg, Germany 15:00

Coffee Break

15:30-17:00

Hall A

SATELLITE SYMPOSIUM SPONSORED BY GSK: SUCCESSES AND CHALLENGES IN PAEDIATRICS WITH VARICELLA, ROTAVIRUS AND PERTUSSIS VACCINATION Chairpersons: V. Papaevangelou, Greece F. Meurice, Belgium Time 15:30

WELCOME AND INTRODUCTION V. Papaevangelou, Athens, Greece

15:35

OVERVIEW OF SUCCESSES AND CHALLENGES WITH PAEDIATRIC VACCINES M. Sáfadi, Sao Paulo, Brazil

15:50

CHALLENGES AND VALUE OF VARICELLA VACCINATION V. Papaevangelou, Athens, Greece

16:05

ROTAVIRUS VACCINATION: IMPLEMENTATION AND IMPACT J. Gray, Norwich, UK

16:25

IMPROVING VACCINATION STRATEGIES TO HELP PROTECT AGAINST PERTUSSIS THROUGHOUT LIFE J. Roord, Amsterdam, The Netherlands

16:45

OVERALL CONCLUSION AND Q&A

17:00

Coffee Break

1

As at April 29, 2012

Tuesday, May 8, 2012 17:30-19:00

Hall A

SATELLITE SYMPOSIUM - SPONSORED BY NOVARTIS: WHICH WAY FORWARD IN PROTECTING CHILDREN FROM INFLUENZA? Chairperson: J. Oxford, UK Time 17:30

CHAIR’S INTRODUCTION J. Oxford, London, UK

17:35

WHY IS THERE A NEED TO PROTECT CHILDREN FROM INFLUENZA? J. Oxford, London, UK

17:55

WHAT IS THE ECONOMIC COST OF INFLUENZA IN CHILDREN? T. Szucs, Zurich, Switzerland

18:10

WHAT BENEFIT DOES A SECOND B STRAIN BRING TO AN ADJUVANTED INFLUENZA VACCINE? S. Black, Cincinnati, OH, USA

18:25

DEBATE: WHICH POPULATIONS TO PRIORITIZE: THOSE IN DIRECT NEED OF PROTECTION (6